Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial

BACKGROUND. Both human immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may increase cardiovascular disease (CVD) risk. Vascular function assessments can be used to study CVD pathogenesis. We compared the effect of immediate versus deferred ART initiation at CD4 counts >500...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Baker, Jason V., Hullsiek, Katherine Huppler, Engen, Nicole Wyman, Nelson, Ray, Chetchotisakd, Ploenchan, Gerstoft, Jan, Jessen, Heiko, Losso, Marcelo, Markowitz, Norman, Munderi, Paula, Papadopoulos, Antonios, Shuter, Jonathan, Rappoport, Claire, Pearson, Mary T., Finley, Elizabeth, Babiker, Abdel, Emery, Sean, Duprez, Daniel
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
Major Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5144656/
https://ncbi.nlm.nih.gov/pubmed/27942541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofw213
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires